Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Inflammation and PARK2[original query] |
---|
Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease. Oncotarget 2016 Jun . Lee SeungBaek, She Jun, Deng Bo, Kim JungJin, de Andrade Mariza, Na Jie, Sun Zhifu, Wampfler Jason A, Cunningham Julie M, Wu Yanhong, Limper Andrew H, Aubry Marie-Christine, Wendt Chris, Biterman Peter, Yang Ping, Lou Zhenk |
Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 2019 7 116 (31): 15616-15624. Fava Vinicius M, Xu Yong Zhong, Lettre Guillaume, Van Thuc Nguyen, Orlova Marianna, Thai Vu Hong, Tao Shao, Croteau Nathalie, Eldeeb Mohamed A, MacDougall Emma J, Cambri Geison, Lahiri Ramanuj, Adams Linda, Fon Edward A, Trempe Jean-François, Cobat Aurélie, Alcaïs Alexandre, Abel Laurent, Schurr Erw |
ADHD-associated PARK2 copy number variants: A pilot study on gene expression and effects of supplementary deprivation in patient-derived cell lines. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2022 8 189 (7-8): 257-270. Radtke Franziska, Palladino Viola Stella, McNeill Rhiannon V, Chiocchetti Andreas G, Haslinger Denise, Leyh Matthias, Gersic Danijel, Frank Markus, Grünewald Lena, Klebe Stephan, Brüstle Oliver, Günther Katharina, Edenhofer Frank, Kranz Thorsten M, Reif Andreas, Kittel-Schneider Sar |
- Page last reviewed:Feb 1, 2024
- Content source: